News & media

  • COMPANY ANNOUNCEMENT

    Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares

  • COMPANY ANNOUNCEMENT

    Total number of shares and voting rights in Zealand Pharma at September 30, 2022

  • PRESS RELEASE

    Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58th Annual Meeting of the European Association for the Study of Diabetes (EASD)

  • COMPANY ANNOUNCEMENT

    Zealand Pharma grants warrants to employees in Denmark

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

  • PRESS RELEASE

    Zealand Pharma to Participate in Morgan Stanley 20th Annual Global Healthcare Conference

  • COMPANY ANNOUNCEMENT

    Total number of shares and voting rights in Zealand Pharma at August 31, 2022

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Appoints Henriette Wennicke as Chief Financial Officer

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Announces Financial Results for the First Half of 2022

  • PRESS RELEASE

    Updated notice to holders of ADSs regarding termination of Deposit Agreement

  • COMPANY ANNOUNCEMENT

    Zealand Pharma Announces Voluntary Delisting of American Depositary Shares from the U.S.-Based Nasdaq Global Select Market

Corporate management

  • Adam ALR0640

    Adam Steensberg - President and Chief Executive Officer

  • Zealand Pharma 0285 FIN

    Adam Steensberg - President and Chief Executive Officer

  • Adam ALR0631

    Adam Steensberg - President and Chief Executive Officer

  • Henriette ALR0758

    Henriette Wennicke - Executive Vice President and Chief Financial Officer

  • Christina ALR0693 V2

    Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer

  • David ALR1003

    David Kendall - Executive Vice President, Research & Development and Chief Medical Officer

  • Ivan ALR0873

    Ivan Møller - Executive Vice President and Chief Operating Officer

  • Utpal Singh 1

    Utpal Singh - Executive Vice President and Chief Scientific Officer

  • Utpal Singh 2

    Utpal Singh - Executive Vice President and Chief Scientific Officer

  • Steven Johnson

    Steven Johnson - Executive Vice President, Chief Development Officer

  • Eric Cox ALR8394

    Eric Cox - Executive Vice President, Chief Commercial Officer

Research and development

Sustainability

Logos and icons

Zealand Pharma 1503

Stay up-to-date with the latest news from Zealand

Sign-up to receive press releases and company announcements directly to your inbox

Subscribe to news

Investor and Media contacts